These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 24922496

  • 1. Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation.
    Beach SR, Kostis WJ, Celano CM, Januzzi JL, Ruskin JN, Noseworthy PA, Huffman JC.
    J Clin Psychiatry; 2014 May; 75(5):e441-9. PubMed ID: 24922496
    [Abstract] [Full Text] [Related]

  • 2. A comparison of the risk of QT prolongation among SSRIs.
    Funk KA, Bostwick JR.
    Ann Pharmacother; 2013 Oct; 47(10):1330-41. PubMed ID: 24259697
    [Abstract] [Full Text] [Related]

  • 3. QT interval prolongation in users of selective serotonin reuptake inhibitors in an elderly surgical population: a cross-sectional study.
    van Haelst IM, van Klei WA, Doodeman HJ, Warnier MJ, De Bruin ML, Kalkman CJ, Egberts TC.
    J Clin Psychiatry; 2014 Jan; 75(1):15-21. PubMed ID: 24345304
    [Abstract] [Full Text] [Related]

  • 4. Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination. Interactions and therapeutic uses.
    Taylor D.
    Br J Psychiatry; 1995 Nov; 167(5):575-80. PubMed ID: 8564311
    [Abstract] [Full Text] [Related]

  • 5. QTc intervals in drug poisoning patients with tricyclic antidepressants and selective serotonin reuptake inhibitors.
    Açikalin A, Satar S, Avci A, Topal M, Kuvandk G, Sebe A.
    Am J Ther; 2010 Nov; 17(1):30-3. PubMed ID: 19417591
    [Abstract] [Full Text] [Related]

  • 6. A comparative study of QT prolongation with serotonin reuptake inhibitors.
    Ojero-Senard A, Benevent J, Bondon-Guitton E, Durrieu G, Chebane L, Araujo M, Montastruc F, Montastruc JL.
    Psychopharmacology (Berl); 2017 Oct; 234(20):3075-3081. PubMed ID: 28770276
    [Abstract] [Full Text] [Related]

  • 7. Citalopram, QTc Prolongation, and Torsades de Pointes.
    Tampi RR, Balderas M, Carter KV, Tampi DJ, Moca M, Knudsen A, May J.
    Psychosomatics; 2015 Oct; 56(1):36-43. PubMed ID: 25619672
    [Abstract] [Full Text] [Related]

  • 8. Use of selective serotonin re-uptake inhibitors and the heart rate corrected QT interval in a real-life setting: the population-based Rotterdam Study.
    Maljuric NM, Noordam R, Aarts N, Niemeijer MN, van den Berg ME, Hofman A, Kors JA, Stricker BH, Visser LE.
    Br J Clin Pharmacol; 2015 Oct; 80(4):698-705. PubMed ID: 25966843
    [Abstract] [Full Text] [Related]

  • 9. Low-dose escitalopram for 2 days associated with corrected QT interval prolongation in a middle-aged woman: a case report and literature review.
    Tseng PT, Lee Y, Lin YE, Lin PY.
    Gen Hosp Psychiatry; 2012 Oct; 34(2):210.e13-5. PubMed ID: 22133983
    [Abstract] [Full Text] [Related]

  • 10. Pharmacotherapeutic determinants for QTc interval prolongation in Japanese patients with mood disorder.
    Okayasu H, Ozeki Y, Fujii K, Takano Y, Saeki Y, Hori H, Horie M, Higuchi T, Kunugi H, Shimoda K.
    Pharmacopsychiatry; 2012 Nov; 45(7):279-83. PubMed ID: 22592502
    [Abstract] [Full Text] [Related]

  • 11. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose.
    Isbister GK, Bowe SJ, Dawson A, Whyte IM.
    J Toxicol Clin Toxicol; 2004 Nov; 42(3):277-85. PubMed ID: 15362595
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Selective serotonin reuptake inhibitors for fibromyalgia syndrome.
    Walitt B, Urrútia G, Nishishinya MB, Cantrell SE, Häuser W.
    Cochrane Database Syst Rev; 2015 Jun 05; 2015(6):CD011735. PubMed ID: 26046493
    [Abstract] [Full Text] [Related]

  • 14. Risk of QT/QTc prolongation among newer non-SSRI antidepressants.
    Jasiak NM, Bostwick JR.
    Ann Pharmacother; 2014 Dec 05; 48(12):1620-8. PubMed ID: 25204465
    [Abstract] [Full Text] [Related]

  • 15. Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.
    Tuccori M, Testi A, Antonioli L, Fornai M, Montagnani S, Ghisu N, Colucci R, Corona T, Blandizzi C, Del Tacca M.
    Clin Ther; 2009 Jun 05; 31 Pt 1():1426-53. PubMed ID: 19698902
    [Abstract] [Full Text] [Related]

  • 16. Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling?
    Vieweg WV, Hasnain M, Howland RH, Hettema JM, Kogut C, Wood MA, Pandurangi AK.
    Am J Med; 2012 Sep 05; 125(9):859-68. PubMed ID: 22748401
    [Abstract] [Full Text] [Related]

  • 17. The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors.
    Hussaarts KGAM, Berger FA, Binkhorst L, Oomen-de Hoop E, van Leeuwen RWF, van Alphen RJ, Mathijssen-van Stein D, de Groot NMS, Mathijssen RHJ, van Gelder T.
    Pharm Res; 2019 Dec 16; 37(1):7. PubMed ID: 31845095
    [Abstract] [Full Text] [Related]

  • 18. The modifying effect of the serum-to-dialysate potassium gradient on the cardiovascular safety of SSRIs in the hemodialysis population: a pharmacoepidemiologic study.
    Assimon MM, Pun PH, Al-Khatib SM, Brookhart MA, Gaynes BN, Winkelmayer WC, Flythe JE.
    Nephrol Dial Transplant; 2022 Oct 19; 37(11):2241-2252. PubMed ID: 35793567
    [Abstract] [Full Text] [Related]

  • 19. Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients.
    Rodriguez de la Torre B, Dreher J, Malevany I, Bagli M, Kolbinger M, Omran H, Lüderitz B, Rao ML.
    Ther Drug Monit; 2001 Aug 19; 23(4):435-40. PubMed ID: 11477329
    [Abstract] [Full Text] [Related]

  • 20. QTc prolongation, torsades de pointes, and psychotropic medications.
    Beach SR, Celano CM, Noseworthy PA, Januzzi JL, Huffman JC.
    Psychosomatics; 2013 Aug 19; 54(1):1-13. PubMed ID: 23295003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.